首页> 外文期刊>Journal of molecular medicine: Official organ of the "Gesellschaft Deutscher Naturforscher und Arzte." >Reduced levels of maternal progesterone during pregnancy increase the risk for allergic airway diseases in females only.
【24h】

Reduced levels of maternal progesterone during pregnancy increase the risk for allergic airway diseases in females only.

机译:孕期孕妇孕激素水平的降低仅增加了女性发生过敏性气道疾病的风险。

获取原文
获取原文并翻译 | 示例
           

摘要

Observational as well as experimental studies support that prenatal challenges seemed to be associated with an increased risk for allergic airway diseases in the offspring. However, insights into biomarkers involved in mediating this risk are largely elusive. We here aimed to test the association between endogenous and exogenous factors documented in pregnant women, including psychosocial, endocrine, and life style parameters, and the risk for allergic airway diseases in the children later in life. We further pursued to functionally test identified factors in a mouse model of an allergic airway response. In a prospectively designed pregnancy cohort (n?=?409 families), women were recruited between the 4th and 12th week of pregnancy. To investigate an association between exposures during pregnancy and the incidence of allergic airway disease in children between 3 and 5 years of age, multiple logistic regression analyses were applied. Further, in prenatally stressed adult offspring of BALB/c-mated BALB/c female mice, asthma was experimentally induced by ovalbumin (OVA) sensitization. In addition to the prenatal stress challenge, some pregnant females were treated with the progesterone derivative dihydrodydrogesterone (DHD). In humans, we observed that high levels of maternal progesterone in early human pregnancies were associated with a decreased risk for an allergic airway disease (asthma or allergic rhinitis) in daughters (adjusted OR 0.92; 95% confidence interval [CI] 0.84 to 1.00) but not sons (aOR 1.02, 95% CI 0.94-1.10). In mice, prenatal DHD supplementation of stress-challenged dams attenuated prenatal stress-induced airway hyperresponsiveness exclusively in female offspring. Reduced levels of maternal progesterone during pregnancy-which can result from high stress perception-increase the risk for allergic airway diseases in females but not in males. Key messages: Lower maternal progesterone during pregnancy increases the risk for allergic airway disease only in female offspring. Prenatal progesterone supplementation ameliorates airway hyperreactivity in prenatally stressed murine offspring.
机译:观察和实验研究都支持,产前挑战似乎与后代中过敏性气道疾病的风险增加有关。但是,对于介导这种风险的生物标志物的见解在很大程度上是难以捉摸的。我们的目标是测试孕妇记录的内源性和外源性因素之间的关联,包括心理社会,内分泌和生活方式参数,以及以后儿童中过敏性气道疾病的风险。我们进一步追求在功能上测试过敏性气道反应的小鼠模型中确定的因素。在一个前瞻性设计的妊娠队列中(n = 409个家庭),在妊娠的第4周和第12周之间招募了妇女。为了调查3到5岁儿童怀孕期间的暴露与过敏性气道疾病发生率之间的关联,应用了多对数Logistic回归分析。此外,在BALB / c交配的BALB / c雌性小鼠的产前应激成年后代中,卵白蛋白(OVA)致敏可诱发哮喘。除了应对产前压力挑战外,还使用孕酮衍生物二氢双氢睾酮(DHD)治疗了一些孕妇。在人类中,我们观察到在人类早期妊娠中高水平的孕激素与降低女儿患过敏性气道疾病(哮喘或过敏性鼻炎)的风险相关(调整后的OR为0.92; 95%的置信区间[CI]为0.84至1.00)但不是儿子(aOR 1.02,95%CI 0.94-1.10)。在小鼠中,产前DHD补充应激挑战的水坝仅在雌性后代中减弱了产前应激诱导的气道高反应性。孕妇在孕期孕激素水平降低(这可能是由于高压力感所致),增加了女性而非男性患过敏性气道疾病的风险。重要信息:孕期孕产妇孕激素降低仅在女性后代中增加发生过敏性气道疾病的风险。产前孕激素补充剂可改善产前应激鼠类后代的气道高反应性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号